Innovative dual-mode biosensing detects caspase-3 activity with enhanced sensitivity, suggesting improved diagnostics.
Enhancing detection sensitivity and reliability is critical in analytical chemistry, particularly for disease diagnosis and biological analysis. Innovative radical polymerization signal amplification strategies, integrated with dual-mode sensing approaches, offer promising avenues for highly sensitive and reliable photoelectrochemical (PEC)-based biosensing. Herein, a novel ultrasensitive PEC-electrochemical (EC) dual-mode biosensing platform was developed for detecting a model analyte of caspase-3, leveraging magnetic metal–organic framework (MOF)-assisted radical polymerization signal amplification in a homogeneous system. Specifically, a magnetic MOF material of MB-UiO-66-NH2 (mMOFs) was employed to load abundant chain-transfer agent (4-cyano-4-(phenylcarbonothioylthio)pentanoic acid, CPAD) to form mMOFs-CPAD, which was immobilized on a 96-well microplate via caspase-3-specific peptides (DEVD peptides). Upon caspase-3 recognition, the DEVD peptides experienced enzymatic cleavage, releasing mMOFs-CPAD. Following magnetic separation, the released mMOFs-CPAD served as a scaffold for grafting poly(ferrocenylmethyl methacrylate) (PFcMMA), thus forming the mMOFs/PFcMMA composite via reversible addition–fragmentation chain-transfer (RAFT) radical polymerization in a homogeneous system. The mMOFs/PFcMMA composite not only effectively suppressed the photocurrent of MWCNTs/PTCA/CdS-modified electrode for PEC assay but also generated an enhanced electrochemical signal for EC assay. Based on the bifunctional polymeric signal probe, the PEC-EC dual-mode biosensing platform exhibited a wide linear detection range of 10–17–10–8 g mL–1 (PEC/EC) and ultralow detection limits of 1.8 ag mL–1 (PEC) and 5.1 ag mL–1 (EC) for ultrasensitive caspase-3 detection. This work pioneers the utilization of RAFT radical polymerization for improving sensitivity and reliability in PEC-based multimode biosensing technologies.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: